BioLargo (BLGO) Stock Price, News & Analysis

Company Overview

BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.

Key Stats

• Today's Range: $0.20 to $0.21
• 50-Day Range: $0.20 to $0.25
• 52-Week Range: $0.16 to $0.32
• Volume: 173,762 shs
• Average Volume: 282,538 shs
• Market Capitalization: $62.23 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BioLargo Stock Analysis - MarketRank™

BioLargo scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for BioLargo.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of BioLargo is -20.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of BioLargo is -20.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

BioLargo has a P/B Ratio of 20.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the outstanding shares of BioLargo have been sold short.

Short Interest Ratio / Days to Cover

BioLargo has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in BioLargo has recently decreased by 81.04%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

BioLargo does not currently pay a dividend.

Dividend Growth

BioLargo does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.00% of the outstanding shares of BioLargo have been sold short.

Short Interest Ratio / Days to Cover

BioLargo has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in BioLargo has recently decreased by 81.04%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for BioLargo this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, BioLargo insiders have not sold or bought any company stock.

Percentage Held by Insiders

19.30% of the stock of BioLargo is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 0.04% of the stock of BioLargo is held by institutions.

BLGO Stock Analysis - Frequently Asked Questions

How have BLGO shares performed this year?

BioLargo's stock was trading at $0.19 at the beginning of 2025. Since then, BLGO shares have increased by 7.9% and is now trading at $0.2050.
View the best growth stocks for 2025 here.

How do I buy shares of BioLargo?

Shares of BLGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of BioLargo own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BioLargo investors own include Hydrofarm Holdings Group (HYFM), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Meta Platforms (META), Micron Technology (MU), Petróleo Brasileiro S.A. - Petrobras (PBR) and Clean Energy Fuels (CLNE).

Company Calendar

• Today: 6/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Construction
• Industry: Chemicals & allied products
• Sub-Industry: Chemicals
• Current Symbol: NASDAQ:BLGO
• CIK: 880242
• Web: www.biolargo.com
• Phone: (888) 400-2863
• Fax: 949-625-9819
• Employees: 30
• Year Founded: 1989

Profitability

• EPS (Most Recent Fiscal Year): ($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$3.50 million
• Net Margins: -11.45%
• Pretax Margin: -19.65%
• Return on Equity: -39.90%
• Return on Assets: -22.06%

Debt

• Debt-to-Equity Ratio: 0.03
• Current Ratio: 2.31
• Quick Ratio: 2.24

Sales & Book Value

• Annual Sales: $12.23 million
• Price / Sales: 5.10
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.01 per share
• Price / Book: 20.50

Miscellaneous

• Outstanding Shares: 304,161,000
• Free Float: 240,168,000
• Market Cap: $62.35 million
• Optionable: Not Optionable
• Beta: 0.12